Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Melanoma Stage IIIB: later-stage trial registry

1 of 1 indexed Melanoma Stage IIIB trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Melanoma Stage IIIB: 1 US clinical trial tracked, 1 recruiting.

Melanoma Stage IIIB is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Philogen S.p.A., running 1 of these trials.

Enrollment posture brief

Registry condition melanoma-stage-iiib

OPEN 1 | RECR 100% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Melanoma Stage IIIB (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Melanoma Stage IIIB

Melanoma Stage IIIB lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Melanoma Stage IIIB on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Melanoma Stage IIIB is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Philogen S.p.A. 1 trials

Named interventions

Most-linked intervention names on Melanoma Stage IIIB records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Adjuvant therapy Drug
1 trials
Daromun Drug
1 trials
Surgery Procedure
1 trials

US sites by state

Facility locations filed on Melanoma Stage IIIB trials. A trial with sites in several states counts in each.

Virginia 1 trials
Utah 1 trials
Texas 1 trials
Pennsylvania 1 trials
Ohio 1 trials
New York 1 trials
New Jersey 1 trials
North Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Melanoma Stage IIIB page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Melanoma Stage IIIB trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Philogen S.p.A. sponsors the most Melanoma Stage IIIB trials on record, review their full trial history before evaluating a specific study. See Philogen S.p.A.'s trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Melanoma Stage IIIB condition card totals 1 registered trials; most-linked intervention Adjuvant therapy; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.